A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy
Clinical trial NCT03941574 · UNKNOWN
Trial details
- NCT number
- NCT03941574
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2024-05-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.